On November 18, 2024, Samsung Bioepis announced that the European Commission (EC) has approved its aflibercept biosimilar, OPUVIZ.

Likewise, in Nigeria, which I visited back in August, the Labondo Area-Based Durable Solutions Initiative, led by the Adamawa State Government facilitates the reintegration of IDPs and refugee ...

On 17 October, the European Commission (EC) issued its Fourth Annual Report under Article 5(4) of the Foreign Direct Investments (FDI) ...

Days of tension have culminated in a high-stakes vote in parliament that could trigger a financial crisis for the eurozone’s ...

Parliament’s Natural Resources committee voted unanimously Monday to call on Paper Excellence owner Jackson Wijaya to testify ...

JD Sports Fashion Plc has completed its acquisition of Groupe Courir S.A.S. following receipt of conditional clearance from ...

The launch underscores European companies’ and individuals’ commitment to creating a dynamic platform for enhancing trade relations and fostering mutual growth, EuroCham officials say ...

Panama will cancel the registration of six ships sailing under its flag after they were sanctioned by the UK last week ...

After a rough few months for Intercept and Advanz Pharma's Ocaliva on both sides of the Atlantic, the other shoe has dropped for the rare liver disease drug in Europe. | The General Court of the ...

A leaked copy of Ursula von der Leyen's second EU executive's work programme reveals that clean industry and defence are on ...

French lawmakers said they tabled a motion of no-confidence against Prime Minister Michel Barnier on Monday, setting up a ...

Ethiopian authorities should immediately reverse the suspension of three independent human rights organizations and allow ...